180 related articles for article (PubMed ID: 27036853)
1. Incorporation of phosphate into glycogen by glycogen synthase.
Contreras CJ; Segvich DM; Mahalingan K; Chikwana VM; Kirley TL; Hurley TD; DePaoli-Roach AA; Roach PJ
Arch Biochem Biophys; 2016 May; 597():21-9. PubMed ID: 27036853
[TBL] [Abstract][Full Text] [Related]
2. Phosphate incorporation during glycogen synthesis and Lafora disease.
Tagliabracci VS; Heiss C; Karthik C; Contreras CJ; Glushka J; Ishihara M; Azadi P; Hurley TD; DePaoli-Roach AA; Roach PJ
Cell Metab; 2011 Mar; 13(3):274-82. PubMed ID: 21356517
[TBL] [Abstract][Full Text] [Related]
3. Are there errors in glycogen biosynthesis and is laforin a repair enzyme?
Roach PJ
FEBS Lett; 2011 Oct; 585(20):3216-8. PubMed ID: 21930129
[TBL] [Abstract][Full Text] [Related]
4. Structural basis for 2'-phosphate incorporation into glycogen by glycogen synthase.
Chikwana VM; Khanna M; Baskaran S; Tagliabracci VS; Contreras CJ; DePaoli-Roach A; Roach PJ; Hurley TD
Proc Natl Acad Sci U S A; 2013 Dec; 110(52):20976-81. PubMed ID: 24324135
[TBL] [Abstract][Full Text] [Related]
5. Glycogen phosphorylation and Lafora disease.
Roach PJ
Mol Aspects Med; 2015 Dec; 46():78-84. PubMed ID: 26278984
[TBL] [Abstract][Full Text] [Related]
6. Glycogen phosphomonoester distribution in mouse models of the progressive myoclonic epilepsy, Lafora disease.
DePaoli-Roach AA; Contreras CJ; Segvich DM; Heiss C; Ishihara M; Azadi P; Roach PJ
J Biol Chem; 2015 Jan; 290(2):841-50. PubMed ID: 25416783
[TBL] [Abstract][Full Text] [Related]
7. Abnormal metabolism of glycogen phosphate as a cause for Lafora disease.
Tagliabracci VS; Girard JM; Segvich D; Meyer C; Turnbull J; Zhao X; Minassian BA; Depaoli-Roach AA; Roach PJ
J Biol Chem; 2008 Dec; 283(49):33816-25. PubMed ID: 18852261
[TBL] [Abstract][Full Text] [Related]
8. Laforin is a glycogen phosphatase, deficiency of which leads to elevated phosphorylation of glycogen in vivo.
Tagliabracci VS; Turnbull J; Wang W; Girard JM; Zhao X; Skurat AV; Delgado-Escueta AV; Minassian BA; Depaoli-Roach AA; Roach PJ
Proc Natl Acad Sci U S A; 2007 Dec; 104(49):19262-6. PubMed ID: 18040046
[TBL] [Abstract][Full Text] [Related]
9. Lafora disease offers a unique window into neuronal glycogen metabolism.
Gentry MS; Guinovart JJ; Minassian BA; Roach PJ; Serratosa JM
J Biol Chem; 2018 May; 293(19):7117-7125. PubMed ID: 29483193
[TBL] [Abstract][Full Text] [Related]
10. Muscle glycogen remodeling and glycogen phosphate metabolism following exhaustive exercise of wild type and laforin knockout mice.
Irimia JM; Tagliabracci VS; Meyer CM; Segvich DM; DePaoli-Roach AA; Roach PJ
J Biol Chem; 2015 Sep; 290(37):22686-98. PubMed ID: 26216881
[TBL] [Abstract][Full Text] [Related]
11. Novel glycogen synthase kinase 3 and ubiquitination pathways in progressive myoclonus epilepsy.
Lohi H; Ianzano L; Zhao XC; Chan EM; Turnbull J; Scherer SW; Ackerley CA; Minassian BA
Hum Mol Genet; 2005 Sep; 14(18):2727-36. PubMed ID: 16115820
[TBL] [Abstract][Full Text] [Related]
12. Laforin prevents stress-induced polyglucosan body formation and Lafora disease progression in neurons.
Wang Y; Ma K; Wang P; Baba O; Zhang H; Parent JM; Zheng P; Liu Y; Minassian BA; Liu Y
Mol Neurobiol; 2013 Aug; 48(1):49-61. PubMed ID: 23546741
[TBL] [Abstract][Full Text] [Related]
13. Structural mechanism of laforin function in glycogen dephosphorylation and lafora disease.
Raththagala M; Brewer MK; Parker MW; Sherwood AR; Wong BK; Hsu S; Bridges TM; Paasch BC; Hellman LM; Husodo S; Meekins DA; Taylor AO; Turner BD; Auger KD; Dukhande VV; Chakravarthy S; Sanz P; Woods VL; Li S; Vander Kooi CW; Gentry MS
Mol Cell; 2015 Jan; 57(2):261-72. PubMed ID: 25544560
[TBL] [Abstract][Full Text] [Related]
14. Dimeric quaternary structure of human laforin.
Sankhala RS; Koksal AC; Ho L; Nitschke F; Minassian BA; Cingolani G
J Biol Chem; 2015 Feb; 290(8):4552-4559. PubMed ID: 25538239
[TBL] [Abstract][Full Text] [Related]
15. Abnormal glycogen chain length pattern, not hyperphosphorylation, is critical in Lafora disease.
Nitschke F; Sullivan MA; Wang P; Zhao X; Chown EE; Perri AM; Israelian L; Juana-López L; Bovolenta P; Rodríguez de Córdoba S; Steup M; Minassian BA
EMBO Mol Med; 2017 Jul; 9(7):906-917. PubMed ID: 28536304
[TBL] [Abstract][Full Text] [Related]
16. Glycogen hyperphosphorylation underlies lafora body formation.
Turnbull J; Wang P; Girard JM; Ruggieri A; Wang TJ; Draginov AG; Kameka AP; Pencea N; Zhao X; Ackerley CA; Minassian BA
Ann Neurol; 2010 Dec; 68(6):925-33. PubMed ID: 21077101
[TBL] [Abstract][Full Text] [Related]
17. Biophysical characterization of laforin-carbohydrate interaction.
Dias DM; Furtado J; Wasielewski E; Cruz R; Costello B; Cole L; Faria TQ; Baaske P; Brito RM; Ciulli A; Simões I; Macedo-Ribeiro S; Faro C; Geraldes CF; Castanheira P
Biochem J; 2016 Feb; 473(3):335-45. PubMed ID: 26578817
[TBL] [Abstract][Full Text] [Related]
18. Hyperphosphorylation of glucosyl C6 carbons and altered structure of glycogen in the neurodegenerative epilepsy Lafora disease.
Nitschke F; Wang P; Schmieder P; Girard JM; Awrey DE; Wang T; Israelian J; Zhao X; Turnbull J; Heydenreich M; Kleinpeter E; Steup M; Minassian BA
Cell Metab; 2013 May; 17(5):756-67. PubMed ID: 23663739
[TBL] [Abstract][Full Text] [Related]
19. Redox Switch for the Inhibited State of Yeast Glycogen Synthase Mimics Regulation by Phosphorylation.
Mahalingan KK; Baskaran S; DePaoli-Roach AA; Roach PJ; Hurley TD
Biochemistry; 2017 Jan; 56(1):179-188. PubMed ID: 27935293
[TBL] [Abstract][Full Text] [Related]
20. Generation and characterization of a laforin nanobody inhibitor.
Simmons ZR; Sharma S; Wayne J; Li S; Vander Kooi CW; Gentry MS
Clin Biochem; 2021 Jul; 93():80-89. PubMed ID: 33831386
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
